Insider Selling: Laboratory Corp. of America Holdings COO Sells 24,400 Shares of Stock (LH)
Laboratory Corp. of America Holdings (NYSE:LH) COO James Jr. Boyle sold 24,400 shares of the company’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $102.00, for a total value of $2,488,800.00. Following the completion of the sale, the chief operating officer now directly owns 29,988 shares of the company’s stock, valued at approximately $3,058,776. The transaction was disclosed in a filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Piper Jaffray Cos. raised their price target on shares of Laboratory Corp. of America Holdings from $98.00 to $103.00 in a research note to investors on Monday. They now have a “neutral” rating on the stock. Separately, analysts at Goldman Sachs Group Inc. raised their price target on shares of Laboratory Corp. of America Holdings from $91.00 to $98.00 in a research note to investors on Wednesday, October 2nd. They now have a “buy” rating on the stock. Finally, analysts at Cantor Fitzgerald initiated coverage on shares of Laboratory Corp. of America Holdings in a research note to investors on Thursday, September 12th. They set a “buy” rating and a $100.05 price target on the stock. Ten investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $101.00.
Shares of Laboratory Corp. of America Holdings (NYSE:LH) traded down 0.88% on Monday, hitting $99.32. The stock had a trading volume of 702,665 shares. Laboratory Corp. of America Holdings has a 1-year low of $82.15 and a 1-year high of $104.37. The stock’s 50-day moving average is $99.52 and its 200-day moving average is $97.66. The company has a market cap of $9.028 billion and a P/E ratio of 16.51.
Laboratory Corp. of America Holdings (NYSE:LH) last released its earnings data on Friday, October 18th. The company reported $1.80 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.80. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.45 billion. During the same quarter last year, the company posted $1.76 earnings per share. Laboratory Corp. of America Holdings’s revenue was up 3.0% compared to the same quarter last year. On average, analysts predict that Laboratory Corp. of America Holdings will post $7.03 earnings per share for the current fiscal year.
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.